Garheng Kong

(Dr. Garheng Kong M.D., PH.D.)

Currently holds positions in Alimera Sciences Inc, Laboratory Corporation of America Holdings and Strongbridge Biopharma plc

Positions
Position Company Period
Independent Director Alimera Sciences Inc Oct. 1, 2012 -
Independent Director Laboratory Corporation of America Holdings Dec. 1, 2013 -
Lead Independent Director Strongbridge Biopharma plc Nov. 18, 2019 -
Independent Director Melinta Therapeutics Inc Jan. 1, 2016 - June 11, 2019
Independent Chairman of the Board Ocugen Inc July 1, 2012 - Feb. 22, 2019
Independent Chairman of the Board Melinta Therapeutics Inc Nov. 1, 2008 - Jan. 1, 2016
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2021-12-17 2021-12-15
B Purchase
1,600,000 +30.8%
1.25
2,000,000 USD 		1,600,000 +30.8% 1.25 2,000,000 USD
2019-02-19 2019-02-19
US Avedro Inc (AVDR)
B Purchase
142,857 +11.0%
14.00
1,999,998 USD 		142,857 +11.0% 14.00 1,999,998 USD